Health
If you had Covid before you were vaccinated, you might have less immunity than you think, study says
A healthcare worker administers a dose of the Pfizer-BioNTech Covid-19 vaccine at a vaccination clinic in the Peabody Institute Library in Peabody, Massachusetts, U.S., on Wednesday, Jan. 26, 2022. Vanessa Leroy | Bloomberg | Getty Images People who caught Covid-19 before they were vaccinated had a weaker immune response to the shots than those who […]
Read More
Texas judge could invoke 1873 Comstock Act to roll back mail delivery of abortion pill mifepristone
A federal judge in Texas may try to invoke an obscure 19th-century law called the Comstock Act to roll back mail delivery of the abortion pill mifepristone. Judge Matthew Kacsmaryk of the U.S. Northern District of Texas heard oral arguments Wednesday in a closely watched case in which medical associations who oppose abortion are challenging […]
Read More
Biden signs legislation to declassify certain intelligence on Covid pandemic origins
U.S. President Joe Biden delivers remarks during a reception celebrating Nowruz in the East Room at the White House in Washington, March 20, 2023. Kevin Lamarque | Reuters President Joe Biden on Monday signed legislation requiring the Office of the Director of National Intelligence to declassify information on any possible links between a lab in […]
Read More
For investors looking for solid ground in an uncertain market, balance sheet is king
Amid ongoing market volatility and renewed fears about the health of the banking sector, investors and analysts are increasingly targeting the stocks of companies with stellar balance sheets. Eleven Club holdings stand out, with chipmaker Nvidia (NVDA) and Google parent Alphabet (GOOGL) leading the pack. “The Street doesn’t seem to realize that this market loves […]
Read More
FDA staff says Biogen’s ALS drug may have a ‘clinical benefit’ on a rare form of the disease
U.S. Food and Drug Administration staff on Monday said Biogen’s investigational ALS drug may have a “clinical benefit” on a rare and aggressive form of the disease, despite failing a broader late-stage clinical trial last year. The staff made the conclusion in briefing documents ahead of a meeting on Wednesday when a panel of external […]
Read More
Biotech company Illumina pushes back against Carl Icahn’s proxy fight over $7.1 billion Grail deal
Carl Icahn Adam Jeffery | CNBC Biotech company Illumina pushed back Monday against Carl Icahn’s proxy fight over the company’s acquisition of cancer test developer Grail, saying the activist investor’s board nominees “do not add value.” The San Diego-based DNA sequencing company released its latest response to Icahn’s sharp criticism of the $7.1 billion deal […]
Read More
Abortion pill fight: Read the transcript of Texas court hearing on fate of mifepristone
Abortion rights advocates gather in front of the J Marvin Jones Federal Building and Courthouse in Amarillo, Texas, on March 15, 2023. Moises Avila | AFP | Getty Images A federal judge in Texas heard arguments for the first time this week in a closely watched case challenging the Food and Drug Administration’s approval of […]
Read More
WHO calls on China to release data linking Covid origin to raccoon dogs at Wuhan market
A man wearing a face mask as a preventive measure against Covid-19 walks past a Communist Party flag in Wuhan, China, on March 31, 2020. Noel Celis | AFP | Getty Images The World Health Organization on Friday called on China to release new data linking the Covid pandemic’s origins to animal samples at Wuhan […]
Read More
U.S. judge in Texas will soon rule on the abortion pill mifepristone. Here’s what could happen
The Alliance For Hippocratic Medicine wants Judge Kacsmaryk to nullify the FDA’s medical approval of mifepristone, which would effectively ban the abortion pill across the US. Senate Judiciary Committee | YouTube A Texas judge will soon issue a pivotal ruling in a closely watched case challenging the Food and Drug Administration’s approval of the abortion […]
Read More
Sanofi to slash U.S. insulin prices in 2024 after similar cuts by Eli Lilly and Novo Nordisk
A pharmacist holds a box of the drug Lantus SoloStar, made by Sanofi Pharmaceutical, at a pharmacy in Provo, Utah, January 9, 2020. George Frey | Reuters Sanofi on Thursday said it’s planning to cut the U.S. price of its most popular insulin drug by 78% and cap monthly out-of-pocket costs at $35 for people […]
Read More